VPC-18005 structure
|
Common Name | VPC-18005 | ||
---|---|---|---|---|
CAS Number | 339304-10-8 | Molecular Weight | 319.379 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 506.3±52.0 °C at 760 mmHg | |
Molecular Formula | C15H17N3O3S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 260.0±30.7 °C |
Use of VPC-18005VPC-18005 (VPC18005) is a novel small molecule ERG (ETS-related gene) antagonist that inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain, disrupts the ERG binding to DNA (Kd=250 uM); markedly decreases SOX9 expression, inhibits migration and invasion of ERG-overexpressing prostate cancer cells in vitro, and reduces metastasis in a zebrafish xenograft model. |
Name | {2-[(2E)-2-(4-Isopropylbenzylidene)hydrazino]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}acetic acid |
---|---|
Synonym | More Synonyms |
Description | VPC-18005 (VPC18005) is a novel small molecule ERG (ETS-related gene) antagonist that inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain, disrupts the ERG binding to DNA (Kd=250 uM); markedly decreases SOX9 expression, inhibits migration and invasion of ERG-overexpressing prostate cancer cells in vitro, and reduces metastasis in a zebrafish xenograft model. |
---|---|
References | References 1. Butler MS, et al. Oncotarget. 2017 Jun 27;8(26):42438-42454. View Related Products by Target Other Targets |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 506.3±52.0 °C at 760 mmHg |
Molecular Formula | C15H17N3O3S |
Molecular Weight | 319.379 |
Flash Point | 260.0±30.7 °C |
Exact Mass | 319.099060 |
LogP | 2.72 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.647 |
{2-[(2E)-2-(4-Isopropylbenzylidene)hydrazino]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}acetic acid |
2-(2-{(Z)-2-[(E)-(4-isopropylphenyl)methylidene]hydrazono}-4-oxo-1,3-thiazolan-5-yl)acetic acid |
5-Thiazoleacetic acid, 4,5-dihydro-2-[(2E)-2-[[4-(1-methylethyl)phenyl]methylene]hydrazinyl]-4-oxo- |
MFCD00758307 |
MFCD28248832 |